LFA-1 antagonists as agents limiting human immunodeficiency virus type 1 infection and transmission and potentiating the effect of the fusion inhibitor T-20

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 11, 2009, Pages 4656-4666

  Tardif, Mélanie R ^a   Gilbert, Caroline ^b   Thibault, Sandra ^a   Fortin, Jean François ^c   Tremblay, Michel J ^a  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c Boehringer Ingelheim   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENFUVIRTIDE; INTERCELLULAR ADHESION MOLECULE 1; MEVINOLIN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; XVA 143;

ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYMPHOCYTE PROLIFERATION; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; VIRION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 70350267052     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00117-09     Document Type: Article

References (65)

1. Abbate, I., F. Dianzani, F. Bianchi, G. Mosiello, F. Carletti, D. Fiumara, and M. R. Capobianchi. 1999. RANTES stimulates cell-mediated transmission of HIV-1 infection. J. Interferon Cytokine Res. 19:345-350. (Pubitemid 29210682)
2. Arias, R. A., L. D. Munoz, and M. A. Munoz-Fernandez. 2003. Transmission of HIV-1 infection between trophoblast placental cells and T-cells take place via an LFA-1-mediated cell to cell contact. Virology 307:266-277.
3. Arthos, J., C. Cicala, E. Martinelli, K. Macleod, D. Van Ryk, D. Wei, Z. Xiao, T. D. Veenstra, T. P. Conrad, R. A. Lempicki, S. McLaughlin, M. Pascuccio, R. Gopaul, J. McNally, C. C. Cruz, N. Censoplano, E. Chung, K. N. Reitano, S. Kottilil, D. J. Goode, and A. S. Fauci. 2008. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat. Immunol. 9:301-309.
4. Barbeau, B., J. F. Fortin, N. Genois, and M. J. Tremblay. 1998. Modulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assay. J. Virol. 72:7125-7136. (Pubitemid 28377841)
5. Bastiani, L., S. Laal, M. Kim, and S. Zolla-Pazner. 1997. Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions. J. Virol. 71:3444-3450. (Pubitemid 27172354)
6. Beauséjour, Y., and M. J. Tremblay. 2004. Susceptibility of HIV type 1 to the fusion inhibitor T-20 is reduced on insertion of host intercellular adhesion molecule 1 in the virus membrane. J. Infect. Dis. 190:894-902.
7. Bounou, S., J.-F. Giguère, R. Cantin, C. Gilbert, M. Imbeault, G. Martin, and M. J. Tremblay. 2004. The importance of virus-associated host ICAM-1 in human immunodeficiency virus type 1 dissemination depends on the cellular context. FASEB J. 18:1294-1296. (Pubitemid 39561581)
8. +-T-cell depletion in human lymphoid tissue, a major site of replication in vivo. J. Virol. 76:1004-1014.
9. Cantin, R., J. F. Fortin, and M. Tremblay. 1996. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. Virology 218:372-381. (Pubitemid 26163831)
10. Cantin, R., G. Martin, and M. J. Tremblay. 2001. A novel virus capture assay reveals a differential acquisition of host HLA-DR by clinical isolates of human immunodeficiency virus type 1 expanded in primary human cells depending on the nature of producing cells and the donor source. J. Gen. Virol. 82:2979-2987.
11. Capobianchi, M. R., S. Fais, C. Castilletti, M. Gentile, F. Ameglio, and F. Dianzani. 1994. A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles. J. Infect. Dis. 169:886-889.
12. Carr, J. M., H. Hocking, P. Li, and C. J. Burrell. 1999. Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes. Virology 265:319-329. (Pubitemid 30022226)
13. Cather, J. C., J. C. Cather, and A. Menter. 2003. Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab. Expert Opin. Biol. Ther. 3:361-370.
14. Curley, G. P., H. Blum, and M. J. Humphries. 1999. Integrin antagonists. Cell. Mol. Life Sci. 56:427-441.
15. del Real, G., S. Jimenez-Baranda, E. Mira, R. A. Lacalle, P. Lucas, C. Gomez-Mouton, M. Alegret, J. M. Pena, M. Rodriguez-Zapata, M. Alvarez-Mon, A. C. Martinez, and S. Manes. 2004. Statins inhibit HIV-1 infection by down-regulating Rho activity. J. Exp. Med. 200:541-547.
16. De Milito, A. 2004. B lymphocyte dysfunctions in HIV infection. Curr. HIV Res. 2:11-21.
17. Dimitrov, D. S., R. L. Willey, H. Sato, L. J. Chang, R. Blumenthal, and M. A. Martin. 1993. Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 67:2182-2190. (Pubitemid 23088394)
18. Dornadula, G., H. Zhang, S. Shetty, and R. J. Pomerantz. 1999. HIV-1 virions produced from replicating peripheral blood lymphocytes are more infectious than those from nonproliferating macrophages due to higher levels of intravirion reverse transcripts: implications for pathogenesis and transmission. Virology 253:10-16. (Pubitemid 29391554)
19. Dustin, M. L., T. G. Bivona, and M. R. Philips. 2004. Membranes as messengers in T cell adhesion signaling. Nat. Immunol. 5:363-372.
20. Dustin, M. L., and T. A. Springer. 1989. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341:619-624.
21. Fortin, J.-F., B. Barbeau, H. Hedman, E. Lundgren, and M. J. Tremblay. 1999. Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection. Virology 257:228-238.
22. Fortin, J.-F., R. Cantin, G. Lamontagne, and M. Tremblay. 1997. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 71:3588-3596.
23. Fortin, J.-F., R. Cantin, and M. J. Tremblay. 1998. T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. J. Virol. 72:2105-2112.
24. Garrido, M., A. Mozos, A. Martinez, F. Garcia, A. Serafin, V. Morente, M. Caballero, C. Gil, E. Fumero, J. M. Miro, N. Climent, J. M. Gatell, and L. Alos. 2007. HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infection. J. Acquir. Immune Defic. Syndr. 46:268-274.
25. Geijtenbeek, T. B., D. S. Kwon, R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, J. Middel, I. L. Cornelissen, H. S. Nottet, V. N. KewalRamani, D. R. Littman, C. G. Figdor, and Y. van Kooyk. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587-597.
26. Giguère, J.-F., and M. J. Tremblay. 2004. Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1. J. Virol. 78:12062-12065.
27. Gilbert, C., C. Barat, R. Cantin, and M. J. Tremblay. 2007. Involvement of Src and Syk tyrosine kinases in HIV-1 transfer from dendritic cells to CD4+ T lymphocytes. J. Immunol. 178:2862-2871. (Pubitemid 46333164)
28. Gilbert, C., M. Bergeron, S. Méthot, J.-F. Giguère, and M. J. Tremblay. 2005. Statins could be used to control replication of some viruses, including HIV-1. Viral Immunol. 18:474-489.
29. Gottlieb, A., J. G. Krueger, R. Bright, M. Ling, M. Lebwohl, S. Kang, S. Feldman, M. Spellman, K. Wittkowski, H. D. Ochs, P. Jardieu, R. Bauer, M. White, R. Dedrick, and M. Garovoy. 2000. Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis. J. Am. Acad. Dermatol. 42:428-435.
30. Groot, F., T. W. Kuijpers, B. Berkhout, and E. C. de Jong. 2006. Dendritic cell-mediated HIV-1 transmission to T cells of LAD-1 patients is impaired due to the defect in LFA-1. Retrovirology 3:75. (Pubitemid 44742669)
31. Groot, F., T. M. van Capel, M. L. Kapsenberg, B. Berkhout, and E. C. de Jong. 2006. Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition. Blood 108:1957-1964. (Pubitemid 44395006)
32. Harlan, J. M., and R. K. Winn. 2002. Leukocyte-endothelial interactions: clinical trials of anti-adhesion therapy. Crit. Care Med. 30:S214-S219.
33. Hildreth, J. E., and R. J. Orentas. 1989. Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 244:1075-1078. (Pubitemid 19152298)
34. Jolly, C., K. Kashefi, M. Hollinshead, and Q. J. Sattentau. 2004. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J. Exp. Med. 199:283-293.
35. Jolly, C., I. Mitar, and Q. J. Sattentau. 2007. Adhesion molecule interactions facilitate human immunodeficiency virus type 1-induced virological synapse formation between T cells. J. Virol. 81:13916-13921. (Pubitemid 350247884)
36. Katagiri, K., A. Maeda, M. Shimonaka, and T. Kinashi. 2003. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat. Immunol. 4:741-748.
37. Kato, T., H. Hashikabe, C. Iwata, K. Akimoto, and Y. Hattori. 2004. Statin blocks Rho/Rho-kinase signalling and disrupts the actin cytoskeleton: relationship to enhancement of LPS-mediated nitric oxide synthesis in vascular smooth muscle cells. Biochim. Biophys. Acta 1689:267-272.
38. Kim, M., C. V. Carman, and T. A. Springer. 2003. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 301:1720-1725. (Pubitemid 37174365)
39. Liao, J. K., and U. Laufs. 2005. Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 45:89-118.
40. Lub, M., Y. van Kooyk, and C. G. Figdor. 1995. Ins and outs of LFA-1. Immunol. Today 16:479-483.
41. Martin, G., and M. J. Tremblay. 2004. HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo. Clin. Immunol. 111:275-285.
42. Ng, T. T., C. Guntermann, K. E. Nye, J. M. Parkin, J. Anderson, J. E. Norman, and W. J. Morrow. 1995. Adhesion co-receptor expression and intracellular signalling in HIV disease: implications for immunotherapy. AIDS 9:337-343.
43. Odds, F. C. 2003. Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 52:1.
44. Piguet, V., and Q. Sattentau. 2004. Dangerous liaisons at the virological synapse. J. Clin. Investig. 114:605-610.
45. Platt, E. J., K. Wehrly, S. E. Kuhmann, B. Chesebro, and D. Kabat. 1998. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72:2855-2864. (Pubitemid 28175522)
46. Puigdomenech, I., M. Massanella, N. Izquierdo-Useros, R. Ruiz-Hernandez, M. Curriu, M. Bofill, J. Martinez-Picado, M. Juan, B. Clotet, and J. Blanco. 2008. HIV transfer between CD4 T cells does not require LFA-1 binding to ICAM-1 and is governed by the interaction of HIV envelope glycoprotein with CD4. Retrovirology 5:32. (Pubitemid 351619159)
47. Rothlein, R., and T. A. Springer. 1986. The requirement for lymphocyte function-associated antigen 1 in homotypic leukocyte adhesion stimulated by phorbol ester. J. Exp. Med. 163:1132-1149.
48. Rudnicka, D., J. Feldmann, F. Porrot, S. Wietgrefe, S. Guadagnini, M. C. Prevost, J. Estaquier, A. T. Haase, N. Sol-Foulon, and O. Schwartz. 2009. Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J. Virol. 83:6234-6246.
49. Salas, A., M. Shimaoka, A. N. Kogan, C. Harwood, U. H. von Andrian, and T. A. Springer. 2004. Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction. Immunity 20:393-406.
50. Salas, A., M. Shimaoka, U. Phan, M. Kim, and T. A. Springer. 2006. Transition from rolling to firm adhesion can be mimicked by extension of integrin alphaLbeta2 in an intermediate affinity state. J. Biol. Chem. 281:10876-10882.
51. Sanders, R. W., E. C. de Jong, C. E. Baldwin, J. H. Schuitemaker, M. L. Kapsenberg, and B. Berkhout. 2002. Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells. J. Virol. 76:7812-7821. (Pubitemid 34761003)
52. Shimaoka, M., A. Salas, W. Yang, G. Weitz-Schmidt, and T. A. Springer. 2003. Small molecule integrin antagonists that bind to the beta2 subunit I-like domain and activate signals in one direction and block them in the other. Immunity 19:391-402. (Pubitemid 37153415)
53. Shimaoka, M., and T. A. Springer. 2004. Therapeutic antagonists and the conformational regulation of the beta2 integrins. Curr. Top. Med. Chem. 4:1485-1495.
54. Shimaoka, M., T. Xiao, J. H. Liu, Y. Yang, Y. Dong, C. D. Jun, A. McCormack, R. Zhang, A. Joachimiak, J. Takagi, J. H. Wang, and T. A. Springer. 2003. Structures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 112:99-111. (Pubitemid 36106422)
55. Takagi, J., B. M. Petre, T. Walz, and T. A. Springer. 2002. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 110:599-611. (Pubitemid 35247840)
56. + T lymphocytes by favoring cytosolic delivery of viral material. J. Virol. 77:12299-12309.
57. Tardif, M. R., and M. J. Tremblay. 2005. Regulation of LFA-1 activity through cytoskeleton remodeling and signaling components modulates the efficiency of HIV type-1 entry in activated CD4+ T lymphocytes. J. Immunol. 175:926-935.
58. Terrazas-Aranda, K., Y. Van Herrewege, D. Hazuda, P. Lewi, R. Costi, R. Di Santo, A. Cara, and G. Vanham. 2008. Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection. Antimicrob. Agents Chemother. 52:2544-2554.
59. Turville, S. G., J. J. Santos, I. Frank, P. U. Cameron, J. Wilkinson, M. Miranda-Saksena, J. Dable, H. Stossel, N. Romani, M. Piatak, Jr., J. D. Lifson, M. Pope, and A. L. Cunningham. 2004. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103:2170-2179.
60. van Kooyk, Y., P. van de Wiel-van Kemenade, P. Weder, T. W. Kuijpers, and C. G. Figdor. 1989. Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes. Nature 342:811-813.
61. van Kooyk, Y., S. J. van Vliet, and C. G. Figdor. 1999. The actin cytoskeleton regulates LFA-1 ligand binding through avidity rather than affinity changes. J. Biol. Chem. 274:26869-26877.
62. Verhulst, A., P. C. D'Haese, and M. E. De Broe. 2004. Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells. J. Am. Soc. Nephrol. 15:2249-2257.
63. Vermot-Desroches, C., D. Rigal, S. Escaich, J. Bernaud, C. Pichoud, J. P. Lamelin, and C. Trepo. 1991. Functional epitope analysis of the human CD11a/CD18 molecule (LFA-1, lymphocyte function-associated antigen 1) involved in HIV-1-induced syncytium formation. Scand. J. Immunol. 34:461-470.
64. Wang, Y., D. Li, R. Nurieva, J. Yang, M. Sen, R. Carreno, S. Lu, B. W. McIntyre, J. J. Molldrem, G. B. Legge, and Q. Ma. 2009. LFA-1 affinity regulation is necessary for the activation and proliferation of naive T cells. J. Biol. Chem. 284:12645-12653.
65. Weitz-Schmidt, G., S. Chreng, and S. Riek. 2009. Allosteric LFA-1 inhibitors modulate natural killer cell function. Mol. Pharmacol. 75:355-362.